Please login to the form below

Not currently logged in
Email:
Password:

Pfizer tries to quash Trovan report in Nigeria

Pfizer initiates legal action in Nigerian Federal high court to quash a report by the Investigating Committee on Trovan

Pfizer has initiated a legal action in the Abuja division of the Nigerian Federal high court to quash a report by the Investigating Committee on the Trovan (trovafloxacin) clinical trial conducted in Kano state in 1996.

The government had charged Pfizer and eight others with alleged criminal application of trovafloxacin on 200 Nigerian children. The trial, it is alleged, killed many of the children and left others with various permanent disabilities.

The new Pfizer suit has demanded an order of certiorari (a type of writ seeking judicial review) and the action was assigned to Justice Anwuri Chikere for trial.

If successful, the certiorari could nullify the multiple criminal and civil actions against Pfizer Nigeria and individuals Isa Dutse, Scott Hopkins, Debra Williams, Mike Dunne, Samuel Ohuabunwa, Robert Buhl and William Steere, all of whom face a total 23-count charge.

The high court judge had granted Pfizer an extension of time to apply for leave to challenge the report. The accused could not be arraigned as they were not in court at the last adjourned date.

31st July 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...